Contravir Pharmaceut (CTRV) Stock Price & Overview

NASDAQ:CTRV

Current stock price

3.58
+0.02 (+0.56%)
At close:
3.62
+0.04 (+1.12%)
After Hours:

The current stock price of CTRV is 3.58 null. Today CTRV is up by 0.56%. In the past month the price decreased by -31.15%. In the past year, price decreased by -93.09%.

CTRV Key Statistics

52-Week Range3.52 - 61.6
Current CTRV stock price positioned within its 52-week range.
1-Month Range3.52 - 5.2
Current CTRV stock price positioned within its 1-month range.
Market Cap
2.875M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-1.39
Dividend Yield
N/A

CTRV Stock Performance

Today
+0.56%
1 Week
-7.01%
1 Month
-31.15%
3 Months
-53.51%
Longer-term
6 Months -84.50%
1 Year -93.09%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

CTRV Stock Chart

Contravir Pharmaceut / CTRV Daily stock chart

CTRV Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to CTRV. When comparing the yearly performance of all stocks, CTRV is a bad performer in the overall market: 98.87% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
CTRV Full Technical Analysis Report

CTRV Earnings

Next Earnings DateN/A
Last Earnings DateN/A
CTRV Earnings History

CTRV Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y-60.6%
Revenue Next YearN/A
CTRV Forecast & Estimates

CTRV Financial Highlights

Over the last trailing twelve months CTRV reported a non-GAAP Earnings per Share(EPS) of -1.39. The EPS decreased by -120.63% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-4.71M
Industry RankSector Rank
PM (TTM) N/A
ROA -59.63%
ROE -730.21%
Debt/Equity 0.84
Chartmill High Growth Momentum
EPS Q2Q%-10407.69%
Sales Q2Q%N/A
EPS 1Y (TTM)-120.63%
Revenue 1Y (TTM)N/A
CTRV financials

CTRV Ownership

Ownership
Inst Owners1.07%
Shares803.00K
Float347.07K
Ins Owners491.99%
Short Float %N/A
Short RatioN/A
CTRV Ownership

About CTRV

Company Profile

ContraVir Pharmaceuticals Inc. is a biopharmaceutical company. The company is involved in the discovery and development of antiviral therapies. ContraVir Pharmaceuticals Inc. is headquartered in Edison, New Jersey.

Company Info

Contravir Pharmaceut

399 THORNALL STREET FIRST FLOOR

EDISON NJ 08837

CEO: Robert Foster

Phone: 732-902-4000

Contravir Pharmaceut / CTRV FAQ

Can you describe the business of Contravir Pharmaceut?

ContraVir Pharmaceuticals Inc. is a biopharmaceutical company. The company is involved in the discovery and development of antiviral therapies. ContraVir Pharmaceuticals Inc. is headquartered in Edison, New Jersey.


What is the stock price of Contravir Pharmaceut today?

The current stock price of CTRV is 3.58 null. The price increased by 0.56% in the last trading session.


What is the dividend status of Contravir Pharmaceut?

CTRV does not pay a dividend.


What is the ChartMill technical and fundamental rating of CTRV stock?

CTRV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


Where is Contravir Pharmaceut (CTRV) stock traded?

CTRV stock is listed on the Nasdaq exchange.